Pharma - HealthQuill

Women farmers’ inequalities on the rise as global hunger intensifies

One in six people globally suffers from infertility disease: WHO

HQ Team April 4, 2023: About one in six people worldwide suffer from infertility, a disease that disables the male or female reproductive.

by HealthQuill
April 4, 2023
0 Comments

BioNTech SE and Duality Biologics (Suzhou) have signed a $1.5 billion deal to develop and commercialise two cancer antibody drug candidates.

Drugs Medical Pharma

BioNTech, Duality Biologics sign $1.5 billion pact for cancer drugs

HQ Team April 3, 2023: BioNTech SE and Duality Biologics (Suzhou) have signed a $1.5 billion deal to develop and commercialise two cancer.

by HealthQuill
April 3, 2023
0 Comments

Drugs Medical Pharma

Global Pharma recalls eye drops in US after ‘possible’ contamination

The CDC laboratory testing identified the presence of the outbreak strain in opened EzriCare bottles with different lot numbers collected from two states.

by HealthQuill
April 3, 2023
0 Comments

India has granted a complete customs duty exemption for the personal use of medicines to treat rare diseases, including Merc & Co’s Keytruda for cancer therapy.

Drugs Health Pharma

India fully exempts import tax for drugs treating rare diseases

India has granted a complete customs duty exemption for the personal use of medicines to treat rare diseases, including Merc & Co’s Keytruda.

by HealthQuill
March 30, 2023
0 Comments

Aurobindo Pharma, an Indian maker of generic pharmaceuticals and active pharmaceutical ingredients, announced it signed a voluntary sub-licensing with a UN body for developing and marketing a drug to prevent HIV.

Drugs Health Medical Pharma

Aurobindo Pharma signs licensing pact with UN body to fight HIV

Aurobindo Pharma, an Indian maker of generic pharmaceuticals and active pharmaceutical ingredients, announced it signed a voluntary sub-licensing with a UN body for.

by HealthQuill
March 30, 2023
0 Comments

Indian billionaire Azim Premji's private equity and venture capitalist arm, Premji Invest, and Tube Investments, together will acquire Lotus Surgicals for INR 3.8 billion, according to a BSE filing.

Drugs Medical Pharma

Indian billionaires to buy Lotus Surgicals for INR 3.8 billion

Indian billionaire Azim Premji's private equity and venture capitalist arm, Premji Invest, and Tube Investments, together will acquire Lotus Surgicals for INR 3.8.

by HealthQuill
March 30, 2023
0 Comments

US-based Emergent BioSolutions announced that FDA had approved its nasal spray Narcan as an over-the-counter emergency treatment for opioid overuse.

Drugs Health Pharma

FDA clears Emergent’s nasal spray for opioid overuse to sell at pharmacies

US-based Emergent BioSolutions announced that FDA had approved its nasal spray Narcan as an over-the-counter emergency treatment for opioid overuse.

by HealthQuill
March 29, 2023
0 Comments

ndia’s Technology Development Board has signed a pact with Huwel Lifesciences for the validation and commercialisation of rapid real-time PCR reagents for storage and transport at room temperature.

Drugs Medical Pharma

India inks pact with Huwel Lifesciences to make rapid real-time PCR reagents

ndia’s Technology Development Board has signed a pact with Huwel Lifesciences for the validation and commercialisation of rapid real-time PCR reagents for storage.